Medications for Central Nervous System Diseases
5 results
Gadavist (gadobutrol)
(gadobutrol)Bayer HealthCare Pharmaceuticals Inc.
Usage: Gadavist is indicated for MRI of the CNS, breast, magnetic resonance angiography (MRA), and cardiac MRI to detect abnormalities, assess malignant breast disease, evaluate artery disease, and assess myocardial perfusion and late gadolinium enhancement in patients with suspected coronary artery disease.
Gadobutrol (gadobutrol)
(Gadobutrol)Fresenius Kabi USA, LLC
Usage: Gadobutrol injection is indicated for use in MRI of the CNS to visualize blood-brain barrier disruptions, in MRI of the breast for malignant disease assessment, in MRA for vascular disease evaluation, and in cardiac MRI to assess myocardial perfusion and coronary artery disease in adults.
Multihance (gadobenate dimeglumine)
(gadobenate dimeglumine)BRACCO DIAGNOSTICS INC
Usage: MultiHance is indicated for intravenous use in MRI of the central nervous system to visualize lesions with abnormal blood-brain barrier or vascularity. It is also used in magnetic resonance angiography to evaluate adults for renal or aorto-ilio-femoral occlusive vascular disease.
Multihance (gadobenate dimeglumine)
(gadobenate dimeglumine)BRACCO DIAGNOSTICS INC
Usage: MultiHance is indicated for intravenous use in magnetic resonance imaging (MRI) of the central nervous system to visualize lesions with abnormal blood-brain barrier or vascularity in adults and pediatrics. It is also used in magnetic resonance angiography (MRA) for assessing renal and aorto-ilio-femoral vascular diseases.
Vistogard (uridine triacetate)
(uridine triacetate)Wellstat Therapeutics Corporation
Usage: VISTOGARD® is indicated for emergency treatment of adults and pediatric patients after a fluorouracil or capecitabine overdose, or for those experiencing severe toxicity affecting the cardiac or central nervous system within 96 hours of administration. Non-emergent use is not recommended as it may reduce drug efficacy.